← Back to Search

Dietary Supplement

Collagen Supplement for Hair Thinning

N/A
Waitlist Available
Research Sponsored by Scale Media Inc
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Must not have
Anyone with a diagnosed hair loss or hair thinning health condition, except for female pattern baldness (e.g., alopecia areata)
Has any planned cosmetic treatments to the face, including botox, dermal filler, chemical peels, etc.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, month 3, and month 6

Summary

This trial will test a supplement called Live Conscious Beyond Collagen from Scale Media to see if it improves hair and skin health. 50 men and women over 40 with hair thinning will participate in

Who is the study for?
This trial is for men and women over 40 who feel their hair is thinning or shedding. It's not clear what the exclusion criteria are, but typically participants with certain health conditions or those taking medications that could interfere with the study might be excluded.
What is being tested?
The trial tests Live Conscious Beyond Collagen against a placebo to see if it improves hair and skin health. Participants will be randomly assigned to either the supplement group or placebo group in this triple-blinded study, meaning neither researchers nor participants know who's getting the real supplement.
What are the potential side effects?
Since specific side effects aren't listed, generally supplements can cause digestive issues, allergic reactions, or interact with other medications. The actual side effects would depend on the ingredients of Live Conscious Beyond Collagen.

Eligibility Criteria

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have a condition causing hair loss or thinning, but it's not female pattern baldness.
Select...
I plan to undergo cosmetic facial treatments.
Select...
I am currently treating my hair loss or have done so in the last three months.
Select...
I am currently using products to make my hair thicker or grow.
Select...
I have had surgery or an invasive treatment in the past 6 months.
Select...
I have not had a major illness in the last three months.
Select...
I am currently receiving or have recently finished chemotherapy or radiotherapy.
Select...
I have not had a hair transplant in the last year.
Select...
I am not pregnant, breastfeeding, or trying to conceive.
Select...
I am currently taking iron supplements.
Select...
I plan to undergo chemical hair treatments during the study.
Select...
I am currently on, or have recently stopped, prescription hair loss medication.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, month 3, and month 6
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, month 3, and month 6 for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in Hair Density and Hair Volume
Secondary study objectives
Change in Skin Health (Fine Lines, Wrinkles, Texture, and Elasticity)

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Live Conscious Beyond Collagen SupplementExperimental Treatment1 Intervention
Participants in this arm will receive the Live Conscious Beyond Collagen supplement. The supplement contains Vitamin C (90 mg), Biotin (2500 mcg), and a Proprietary Collagen Blend (10.1 g) including Types I \& III Bovine Collagen, Type II Marine Collagen, Type II Chicken Sternum Collagen, and Types I, V \& X Eggshell Membrane Collagen.
Group II: PlaceboPlacebo Group1 Intervention
Participants in this arm will receive a placebo product. The placebo contains Maltodextrin.

Find a Location

Who is running the clinical trial?

CitruslabsIndustry Sponsor
89 Previous Clinical Trials
4,680 Total Patients Enrolled
2 Trials studying Alopecia
125 Patients Enrolled for Alopecia
Scale Media IncLead Sponsor
4 Previous Clinical Trials
250 Total Patients Enrolled
1 Trials studying Alopecia
100 Patients Enrolled for Alopecia
~8 spots leftby Dec 2024